Business insiders believe the shift from relying on "China hands" to algorithms indicates that foreign giants are intensifying their AI-driven investment research. This is not only because of the ...

The Dynamic Ads optimization initiative represents a paradigm shift in how advertising platforms approach vertical-specific ...

From human-centric automation to smart manufacturing, Harsh Vardhan is guiding Apollo Tyres to an intelligent, AI-powered ...

By the time Carnegie Mellon University (CMU) researcher Hans Moravec published his seminal book on robotics “Mind Children” in 1988, a student at the same institution had created the first version of ...

By Waylon Cunningham NEW YORK, Jan 27 (Reuters) - Four Starbucks CEOs over five years have blamed lost sales on its struggle ...

Proptech promised disruption but delivered prettier middlemen. The next revolution won't be digital; it'll be honest.

Affiliated with the People’s Republic of China (PRC), the Salt Typhoon hacking group was blamed for what was dubbed the worst ...

Nutshell reports that startups must choose CRMs based on growth stages, ensuring alignment with current needs and planning ...

Marsh & McLennan Companies, Inc. ( MRSH) Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Hello, and welcome to Marsh's earnings conference call. Today's call is being recorded. Fourth quarter 2025 ...

Millions of people use chatbots like ChatGPT to share their distress, and the scientific community has warned about the risks vulnerable people face. Generative AI has shaken up psychiatric ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.

Quick Read Eli Lilly (LLY) and Nvidia (NVDA) will invest up to $1B over five years in an AI drug discovery lab. AI could reduce pharma R&D costs by 30% to 40% and shorten timelines by one to four ...